GLAND PHARMA LTD FDA Approval ANDA 207385

ANDA 207385

GLAND PHARMA LTD

FDA Drug Application

Application #207385

Application Sponsors

ANDA 207385GLAND PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INTRAVENOUS50MG/VIAL0OXALIPLATINOXALIPLATIN
002INJECTABLE;INTRAVENOUS100MG/VIAL0OXALIPLATINOXALIPLATIN

FDA Submissions

UNKNOWN; ORIG1AP2017-05-23STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

GLAND PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207385
            [companyName] => GLAND PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"50MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"100MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/23\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.